Pep-Therapy

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Apim Therapeutics

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses for patients with advanced cancers including ovarian cancer and sarcoma.

Peptomyc

The company develops cell-penetrating mini-protein therapeutics for the treatment of cancer patients with solid tumours and intends to license these products to pharmaceutical companies.

APIM Therapeutics AS

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses to treat patients with advanced solid tumours and multiple cancers.

PanCancerT

This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.

Cytovation

This company develops synthetic peptide immunotherapies to treat patients with solid tumours by targeting cancer cell membranes and stimulating immune responses.

Cytovation AS

This company develops peptide-based immunotherapy treatments for patients with solid tumours and cancers driven by the Wnt/β-catenin signalling pathway.

Actym Therapeutics

This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.